Here is a 400-word summary of the content:
Piramal Pharma (PPL), a part of the Piramal group of companies, has expanded its capacity to manufacture Sevoflurane, a critical component used in inhalation anesthesia. The company has set up additional manufacturing capabilities at its Digwal facility, in addition to its existing capacity at its Bethlehem, Pennsylvania, USA facility. This move aims to increase the company’s ability to tap into inhalation anesthesia opportunities in both the USA and Rest of World (ROW) markets.